Topline results that were recently released from Sydnexis’s phase 3 Study of Atropine for the Reduction of Myopia Progression ...

Sydnexis Announces Topline Pivotal Data from Phase 3 STAR Trial of SYD-101 for Patients with Pediatric Progressive Myopia Presented at AMCP Nexus 2025 ...

While the trial met its primary endpoint, the FDA stated in its letter that the application could not be approved in its current form.

UAB School of Optometry professor is joining a national network study to research myopia prevention in children. Myopia, ...

In an exclusive conversation with NDTV Profit’s Tamanna Inamdar, Lenskart CEO Peyush Bansal sheds light on India’s alarming ...

How severe should myopia be in a pediatric patient to justify starting treatment, and when is it appropriate to begin ...

Parents can play an active role in protecting their children’s long-term vision by adopting these expert-recommended daily habits. Read more at straitstimes.com. Read more at straitstimes.com.

Proactive strategies in glaucoma care, including minimally invasive glaucoma surgery (MIGS) and physician decision-making, ...

While the trial met its primary endpoint, the FDA stated in its letter that the application could not be approved in its current form.

Sydnexis, Inc., ( a biopharmaceutical company focused on pediatric progressive myopia (PPM), today announced that the U.S. Food and Drug Administration (FDA) has issued a complete response letter (CRL ...

Claudia Winkleman has been spotted without her trademark eyeliner after quitting Strictly Come Dancing. She and co-star Tess ...